 | | | | Durex, owned by Reckitt Benckiser, has recalled some batches of its "Real Feel" and "Latex Free" condoms in the United Kingdom and Ireland due to concerns they may burst. | | | | | | Indivior Plc notched a legal victory on Tuesday after a U.S. court reaffirmed that a generic rival could not re-launch cheaper versions of the British drugmaker's best-selling opioid addiction treatment in the United States. | | | | | | China's drug watchdog published details on Tuesday of an investigation into a second firm found to have made inferior vaccines, after cabinet vowed tough penalties and fines over a vaccine safety scandal that has sparked widespread anger. | | | | | | Chipotle Mexican Grill Inc has shut a restaurant in Ohio following reports of customers falling sick after eating there, the burrito chain said on Monday. | | | | | | (Reuters Health) - Breastfeeding mothers who drink alcohol may be more likely to have children with cognitive problems than women who abstain while nursing, an Australian study suggests. | | | | | | (Reuters Health) - Even in early adulthood, being overweight is associated with an increased risk of high blood pressure and heart muscle damage that may set the stage for cardiovascular diseases later in life, a UK study suggests. | | | | | | The U.S. Food and Drug Administration (FDA) on Monday approved Progenics Pharmaceuticals Inc's treatment for two types of rare adrenal gland tumors, making it the first drug approved in the United States for this use. | | | | | | (Reuters Health) - How the media reports on suicides may impact whether others decide to kill themselves in the days following the original death, a study suggests. | | | | | | (Reuters Health) - Meat allergies related to tick bites might be at the root of some unexplained severe, life-threatening allergic reactions, a new study suggests. | | | | | | Sienna Biopharmaceuticals Inc said its lead experimental acne treatment failed to meet the main goals of two pivotal trials and that the chances of it clearing a third study appeared weaker, sending its shares tumbling 19 percent. | | | | | | Israel's RedHill Biopharma said on Monday it had positive safety and efficacy results from a late-stage clinical trial with its treatment for Crohn's disease called RHB-104. | | | | | |
